About Merz Therapeutics
Merz Therapeutics is a company based in Frankfurt (Germany). It operates as a Professional Services and Reseller / Distribution. Merz Therapeutics has completed 1 acquisition, including Acorda. Merz Therapeutics offers products and services including Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies. Merz Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Incyte, NGM Biopharmaceuticals and Neurocrine, among others.
- Headquarter Frankfurt, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Merz Therapeutics Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Merz Therapeutics
Merz Therapeutics offers a comprehensive portfolio of products and services, including Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies.
Treatments for movement disorders are developed and provided.
Solutions for liver-related conditions are researched and offered.
Products for skin conditions are formulated and distributed.
Specialized treatments for Parkinson's disease are newly introduced.
Therapies for multiple sclerosis are recently added offerings.
Funding Insights of Merz Therapeutics
Detailed funding history for Merz Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Merz Therapeutics
Merz Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Acorda.
Investment portfolio details for Merz Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Engaged in the development and commercialization of therapies that improve neurological function.
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for Merz Therapeutics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Merz Therapeutics
Detailed financials for Merz Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Merz Therapeutics Comparisons
Peer comparison for Merz Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Merz Therapeutics
Merz Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Incyte, NGM Biopharmaceuticals and Neurocrine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| Locked | Locked | Locked |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| Locked | Locked | Locked |
Small molecule drugs for rare diseases are developed.
|
Detailed competitors of Merz Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Merz Therapeutics
Complete news archive for Merz Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Merz Therapeutics
Merz Therapeutics is headquartered in Frankfurt, Germany. It is registered at Frankfurt, Hesse, Germany.
Merz Therapeutics is engaged in the development and distribution of pharmaceutical solutions targeting chronic health conditions. The company specializes in therapeutic fields such as neurology, hepatology, and dermatology. Innovative treatments for movement disorders, Parkinsons disease, and multiple sclerosis are provided alongside patient-centric services. Operations span across multiple regions including Europe, the Middle East, and North America, with a commitment to sustainability and partnerships for enhanced patient outcomes.
Merz Therapeutics's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
Merz Therapeutics offers Neurology Treatments, Hepatology Solutions, Dermatology Products, Parkinson's Disease Treatments, and Multiple Sclerosis Therapies.
Merz Therapeutics has made 1 acquisition, including Acorda.